/VANI
VANI Stock - Vivani Medical, Inc.
Healthcare|Medical - DevicesNASDAQ
$1.39+0.72%
+$0.01 (+0.72%) • Dec 19
48
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.53
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.53
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for VANI
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.38 – $1.40
TARGET (TP)$1.60
STOP LOSS$1.28
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta3.32
52W High$1.92
52W Low$0.91
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | $-357,000 | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-24,677,000 | $-26,965,000 | $-21,241,000 | $-13,323,000 | $-9,243,000 |
| Net Income | $-23,486,000 | $-25,652,000 | $-13,889,000 | $-12,773,000 | $-9,279,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.43 | $-0.50 | $-0.17 | $-0.33 | $-0.33 |
Company Overview
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
VANIBeat Rate
27%
Last 11 quarters
Avg Surprise
-2.5%
EPS vs Estimate
Beats / Misses
3/5
3 met exactly
Latest EPS
$-0.11
Q4 2025
EPS Surprise History
Q1 24
+14.3%
$-0.12vs$-0.14
Q2 24
0.0%
$-0.12vs$-0.12
Q3 24
+16.7%
$-0.10vs$-0.12
Q4 24
0.0%
$-0.11vs$-0.11
Q1 25
-10.0%
$-0.11vs$-0.10
Q2 25
-10.0%
$-0.11vs$-0.10
Q3 25
-20.0%
$-0.12vs$-0.10
Q4 25
+8.3%
$-0.11vs$-0.12
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 30, 2026 | $-0.10 | — | — | — |
Q4 2025 | Nov 13, 2025 | $-0.12 | $-0.11 | +8.3% | ✓ BEAT |
Q3 2025 | Aug 13, 2025 | $-0.10 | $-0.12 | -20.0% | ✗ MISS |
Q2 2025 | May 13, 2025 | $-0.10 | $-0.11 | -10.0% | ✗ MISS |
Q1 2025 | Mar 31, 2025 | $-0.10 | $-0.11 | -10.0% | ✗ MISS |
Q4 2024 | Nov 13, 2024 | $-0.11 | $-0.11 | 0.0% | = MET |
Q3 2024 | Aug 13, 2024 | $-0.12 | $-0.10 | +16.7% | ✓ BEAT |
Q2 2024 | May 13, 2024 | $-0.12 | $-0.12 | 0.0% | = MET |
Q1 2024 | Mar 26, 2024 | $-0.14 | $-0.12 | +14.3% | ✓ BEAT |
Q4 2023 | Nov 14, 2023 | $-0.13 | $-0.13 | 0.0% | = MET |
Q3 2023 | Aug 14, 2023 | $-0.11 | $-0.13 | -18.2% | ✗ MISS |
Q2 2023 | May 15, 2023 | $-0.11 | $-0.12 | -9.1% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | — | $-0.18 | — | — |
Q4 2022 | Nov 14, 2022 | — | $0.04 | — | — |
Q3 2022 | Aug 11, 2022 | — | $-0.08 | — | — |
Q3 2022 | Jul 4, 2022 | — | $-0.12 | — | — |
Q1 2022 | Mar 28, 2022 | — | $-0.09 | — | — |
Q4 2021 | Nov 12, 2021 | — | $-0.11 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.08 | — | — |
Q2 2021 | May 12, 2021 | — | $-0.09 | — | — |
Latest News
Vivani Medical Q3 EPS $(0.11), Inline
➖ NeutralBenzinga•Nov 13, 2025, 12:47 PM
Vivani Medical Expects To Spin Off Cortigent Unit; Starts Clinical Development Of NPM-139 Semaglutide Implant In Obesity, Chronic Weight Management In 2026
➖ NeutralBenzinga•Nov 13, 2025, 12:47 PM•Also:
Vivani Medical Announces Company Presentation, Unveils Obesity Market Strategy With New GLP-1 Implant Technology
📈 PositiveBenzinga•Nov 10, 2025, 08:19 PM
Reported Sunday, Vivani Medical Prices Registered Direct Offering Of 6M Common Shares And Concurrent Private Placement Of 3,703,703 Shares At $1.62 Per Share
➖ NeutralBenzinga•Oct 27, 2025, 06:26 AM
Vivani Medical Will Temporarily Withdraw Record Date For Planned Spin-Off Of Cortigent Subsidiary, Expects To Announce New Record Date As Soon as Possible
📉 NegativeBenzinga•Oct 3, 2025, 12:32 PM•Also:
Vivani Medical shares are trading higher. Chairman of Vivani Board Gregg Williams bought 2,068,453 shares of the companies stock.
📈 PositiveBenzinga•Sep 17, 2025, 06:41 PM
Vivani Medical Plans To Initiate Phase 1 Clinical Study In NPM-139 Semaglutide Implant Program In First Half Of 2026, Pending Regulatory Clearance
➖ NeutralBenzinga•Sep 4, 2025, 12:36 PM
HC Wainwright & Co. Reiterates Buy on Vivani Medical, Maintains $4 Price Target
📈 PositiveBenzinga•Sep 2, 2025, 11:07 AM
Frequently Asked Questions about VANI
What is VANI's current stock price?
Vivani Medical, Inc. (VANI) is currently trading at $1.39 per share. The stock has moved +0.72% today.
What is the analyst price target for VANI?
No analyst price targets are currently available for this stock.
What sector is Vivani Medical, Inc. in?
Vivani Medical, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is VANI's market cap?
Vivani Medical, Inc. has a market capitalization of $0.08 billion, making it a small-cap company.
Does VANI pay dividends?
No, Vivani Medical, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCRDL
Cardiol Therapeutics Inc.
$1.01
Mkt Cap: $0.1B
EDAP
Edap Tms S.a.
$2.94
Mkt Cap: $0.1B
FONR
FONAR Corporation
$14.94
Mkt Cap: $0.1B
HYPR
Hyperfine, Inc.
$1.10
Mkt Cap: $0.1B
IMA
ImageneBio Inc
$6.18
Mkt Cap: $0.1B
MBOT
Microbot Medical Inc.
$2.08
Mkt Cap: $0.1B
NSPR
InspireMD, Inc.
$1.99
Mkt Cap: $0.1B
ORMP
Oramed Pharmaceuticals Inc.
$2.93
Mkt Cap: $0.1B
QIPT
Quipt Home Medical Corp.
$3.52
Mkt Cap: $0.2B
RCEL
AVITA Medical, Inc.
$3.46
Mkt Cap: $0.1B
Explore stocks similar to VANI for comparison